Sebetralstat: A Rapidly Acting Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary Angioedema

Sebetralstat is a novel, potent, and selective oral plasma kallikrein inhibitor drug candidate in clinical development for the on-demand treatment of hereditary angioedema (HAE). Upon binding, sebetralstat induces a conformational change in the active site of plasma kallikrein, which contributes to...

Full description

Saved in:
Bibliographic Details
Main Authors: Edward P. Feener (Author), Rebecca L. Davie (Author), Nivetha Murugesan (Author), Stephen J. Pethen (Author), Sally L. Hampton (Author), Michael D. Smith (Author), Paul K. Audhya (Author), Chris M. Yea (Author)
Format: Book
Published: MDPI AG, 2024-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available